• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB

CAMBIUM BIO LIMITED

0.00% ! 50.0¢
Market Cap $11.48M  !

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 27/10/25 0 105
27/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
CMB 27/10/25 0 70
27/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  70 
CMB 24/10/25 0 63
TRENDING NEWS

HotCopper Wire Podcast 030 – Least surprising RBA 'hold' ever and the Huang Chicken effect

NEWS
08 Nov 2025
24/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  63 
CMB 24/10/25 0 71
24/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  71 
CMB 17/10/25 0 75
17/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  75 
CMB 16/10/25 0 69
16/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  69 
CMB 16/10/25 0 63
16/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  63 
CMB 16/10/25 0 71
16/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  71 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
27 Oct 15:50
 
Corrective Appendix 3Y Terrence Walts
27 Oct 15:20
 
Change of Directors Interest Notice - TW
24 Oct 08:18
 
Change of Directors Interest Notice - EW
24 Oct 08:18
 
Amended Constitution
17 Oct 10:26
 
Cleansing notice
16 Oct 16:09
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
50.0¢
Change
0.000(0.00%)
Mkt cap ! $11.48M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 200 50.0¢
 

Sellers (Offers)

Price($) Vol. No.
55.0¢ 402 1
View Market Depth
Last trade - 16.21pm 07/11/2025 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.